Kappa Opioid System in Nucleus Accumbens Drives Pain-Induced Negative Affect | Pain Research Forum
Scientists Take a Big Step toward Building a Better Opioid | Newsroom
Chronic Kappa opioid receptor activation modulates NR2B: Implication in treatment resistant depression | Scientific Reports
Opioid receptor modulation of neural circuits in depression: What can be learned from preclinical data? - ScienceDirect
Opioid receptor modulation of neural circuits in depression: What can be learned from preclinical data? - ScienceDirect
κ-opioid receptor - Wikipedia
Frontiers | Dynorphin/kappa opioid receptor system regulation on amygdaloid circuitry: Implications for neuropsychiatric disorders
Researchers identify possible therapeutic target for depression and addiction - The Source - Washington University in St. Louis
Opioids to Treat Depression: The Jury Is Out
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Lowered endogenous mu-opioid receptor availability in subclinical depression and anxiety | Neuropsychopharmacology
Role of kappa-opioid receptors in stress and anxiety-related behavior. - Abstract - Europe PMC
A Systematic Review on the Kappa Opioid Receptor and Its Ligands: New Directions for the Treatment of Pain, Anxiety, Depression, and Drug Abuse | Biological and Medicinal Chemistry | ChemRxiv | Cambridge Open Engage
Frontiers Publishing Partnerships | Mechanisms Underlying the Anti-Suicidal Treatment Potential of Buprenorphine
Dynorphin/kappa-opioid receptor control of dopamine dynamics: Implications for negative affective states and psychiatric disorders - ScienceDirect
Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry
κ Opioid Receptor-Dynorphin Signaling in the Central Amygdala Regulates Conditioned Threat Discrimination and Anxiety | eNeuro
The Role of Dynorphin and the Kappa Opioid Receptor in Schizophrenia and Major Depressive Disorder: A Translational Approach | SpringerLink
Kappa Opioid Receptor Ligands and Pharmacology: Diphenethylamines, a Class of Structurally Distinct, Selective Kappa Opioid Ligands | SpringerLink
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
Dynorphin/Kappa Opioid Receptor Signaling in Preclinical Models of Alcohol, Drug, and Food Addiction - ScienceDirect
Opioid receptor modulation of neural circuits in depression: What can be learned from preclinical data? - ScienceDirect
